As of 4:00pm ET
| -5.56 / -1.73%|
The 24 analysts offering 12-month price forecasts for Regeneron Pharmaceuticals Inc have a median target of 400.00, with a high estimate of 520.00 and a low estimate of 315.00. The median estimate represents a +26.65% increase from the last price of 315.83.
The current consensus among 29 polled investment analysts is to Hold stock in Regeneron Pharmaceuticals Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.